Networking +
Policy +
Member
Career
Choose
AmideBio Awarded SBIR Phase II Grant to Further Development of its Novel Glucagons for the Treatment of Hyperinsulinism
By: Colorado BioScience Association Date: 09/30/2019
BOULDER, CO, September 30, 2019 – AmideBio, LLC, a privately held biopharmaceutical company, announced today that it has received $1.56M in funding through a Phase II Small Business Innovation Researc...
Learn MoreGREFFEX, Inc. Awarded $18.7 Million Contract with NIH to Develop a Plug-and-Play Technology Platform to Expedite Production of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
By: Colorado BioScience Association Date: 09/27/2019
GREFFEX, Inc. (Aurora, CO), a Fitzsimons Innovation Community company, is a transformative leader in genetic engineering. The company was recently awarded an $18.7 million contract with the National I...
Learn MoreWeekly Policy Update: CBSA Submits Comment Letter to CMS Advocating for Patient Access to Timely Precision Diagnostic Information
By: Colorado BioScience Association Date: 09/27/2019
In July the Centers for Medicare and Medicaid Services (CMS) issued the CY 2020 Hospital Outpatient Prospective Payment System (HOPPS) Proposed Rule, which included concerning proposed revisions to th...
Learn MoreBoulder Based Edgewise Therapeutics Closes $50 Million Series B Financing
By: Colorado BioScience Association Date: 09/17/2019
Financing to Support Advancing Company’s Lead Product Candidate for Muscular Dystrophy- Boulder, Colo., (September 17, 2019) – Edgewise Therapeutics, a preclinical company developing small molecule th...
Learn MoreNymbl Science Releases Their August Update
By: Colorado BioScience Association Date: 09/09/2019
Below please find an overview of our progress for the month of August: • We continue to move forward towards closing out our round. We have about $235k remaining with 4 angel pitches lined up in the n...
Learn MoreDenver Business Journal Highlights Colorado’s Life Sciences Ecosystem and Our Leadership In Gene Editing
By: Colorado BioScience Association Date: 09/09/2019
Gene editing is becoming an increasingly common remedy for a variety of ailments, and Boulder area bioscience companies are leading those advancements. Building on research and technology originating...
Learn MoreSomaLogic launches its first SomaSignal™ tests in select medical practices
By: Colorado BioScience Association Date: 09/04/2019
Novel tests based on large-scale protein measurements will first offer personal and precise information about an individual’s cardiometabolic health status and trajectory Boulder, Colo., September 4,...
Learn MoreSecurisyn Medical Partners with Leading Medical Device Design and Development Firm, Meddux
By: Colorado BioScience Association Date: 08/12/2019
HIGHLANDS RANCH, Colo., August 12, 2019 — Securisyn Medical, LLC, dedicated to inspiring the world to collaborate to make airway management safer, has announced a new partnership with Meddux™ Developm...
Learn MoreAllosource Celebrates 25 Years Of Doing More With Life
By: Colorado BioScience Association Date: 08/12/2019
Milestone highlights organization’s growth into one of the largest tissue banks in the U.S. Centennial, Colo. — August 9, 2019 — AlloSource®, an organization dedicated to advancing the science and use...
Learn MoreZoetis Establishes Research Lab At CSU To Explore Immunotherapies For Livestock
By: Colorado BioScience Association Date: 07/30/2019
Zoetis, the world’s leading animal health company, has signed an agreement with Colorado State University to establish a research lab at CSU that will explore the livestock immune system and target ne...
Learn More